Q3 2024 |
44 |
$600M |
+$72.9M |
-$66.9M |
+$6.02M |
HROW, TGTX, OCUL, ARVN, CDXS
|
13F-HR |
11/14/2024, 04:05 PM |
Q2 2024 |
51 |
$438M |
+$74.6M |
-$59.2M |
+$15.3M |
HROW, TGTX, OCUL, RYTM, KROS
|
13F-HR |
8/14/2024, 04:05 PM |
Q1 2024 |
52 |
$459M |
+$77.1M |
-$78.3M |
-$1.2M |
OCUL, HROW, TGTX, KROS, RYTM
|
Restatement |
5/29/2024, 04:05 PM |
Q4 2023 |
47 |
$373M |
+$63.1M |
-$56.4M |
+$6.73M |
HROW, TGTX, SLRN, RYTM, OCUL
|
13F-HR |
2/14/2024, 04:05 PM |
Q3 2023 |
41 |
$305M |
+$48.5M |
-$88.3M |
-$39.8M |
HROW, SLRN, OCUL, TGTX, RYTM
|
13F-HR |
11/14/2023, 08:04 PM |
Q2 2023 |
47 |
$415M |
+$135M |
-$34.6M |
+$100M |
SLRN, HROW, OCUL, TELA, CRNX
|
13F-HR |
8/14/2023, 05:11 PM |
Q1 2023 |
41 |
$334M |
+$42.1M |
-$22M |
+$20.1M |
HROW, OCUL, TELA, RYTM, CRNX
|
13F-HR |
5/12/2023, 06:49 PM |
Q4 2022 |
40 |
$288M |
+$59.8M |
-$44.9M |
+$14.9M |
HROW, TELA, RYTM, OCUL, CRNX
|
13F-HR |
2/10/2023, 04:05 PM |
Q3 2022 |
42 |
$239M |
+$30.3M |
-$40.7M |
-$10.4M |
HROW, OCUL, RYTM, TELA, CRNX
|
13F-HR |
11/14/2022, 04:20 PM |
Q2 2022 |
47 |
$222M |
+$35.6M |
-$57.3M |
-$21.7M |
HROW, OCUL, CDXS, CRNX, CYTK
|
13F-HR |
8/15/2022, 04:03 PM |
Q1 2022 |
45 |
$322M |
+$33.6M |
-$60.4M |
-$26.8M |
OCUL, CDXS, CMRX, HROW, CRNX
|
13F-HR |
5/16/2022, 04:05 PM |
Q4 2021 |
39 |
$471M |
+$55.8M |
-$74.4M |
-$18.7M |
CDXS, OCUL, CMRX, CLDX, HROW
|
13F-HR |
2/14/2022, 04:05 PM |
Q3 2021 |
48 |
$535M |
+$61M |
-$46.9M |
+$14.1M |
OCUL, CLDX, CDXS, CMRX, HROW
|
13F-HR |
11/15/2021, 07:17 PM |
Q2 2021 |
48 |
$573M |
+$45.3M |
-$94.6M |
-$49.3M |
OCUL, CMRX, CLDX, BBIO, CDXS
|
13F-HR |
8/16/2021, 05:13 PM |
Q1 2021 |
58 |
$671M |
+$147M |
-$168M |
-$21.4M |
OCUL, CMRX, TARA, BBIO, CDXS
|
13F-HR |
5/17/2021, 07:03 PM |
Q4 2020 |
59 |
$748M |
+$84M |
-$53M |
+$30.9M |
OCUL, TARA, EIDX, ETON, CDXS
|
13F-HR |
2/12/2021, 05:15 PM |
Q3 2020 |
55 |
$489M |
+$124M |
-$71.9M |
+$51.6M |
OCUL, TARA, ETON, CRDF, AFIB
|
13F-HR |
11/16/2020, 04:30 PM |
Q2 2020 |
48 |
$487M |
+$183M |
-$150M |
+$33.3M |
TARA, OCUL, NLTX, CCXI, ETON
|
13F-HR |
8/14/2020, 04:47 PM |
Q1 2020 |
43 |
$377M |
+$103M |
-$178M |
-$75.1M |
TARA, FTSV, OCUL, NLTX, CDXS
|
13F-HR |
5/15/2020, 04:30 PM |
Q4 2019 |
47 |
$510M |
+$106M |
-$31.7M |
+$74.8M |
EPZM, CDXS, FTSV, STXS, TPTX
|
13F-HR |
2/14/2020, 04:30 PM |
Q3 2019 |
49 |
$277M |
+$67.5M |
-$60.7M |
+$6.82M |
CDXS, STXS, EPZM, IMMY, EIDX
|
13F-HR |
11/14/2019, 04:30 PM |
Q2 2019 |
43 |
$328M |
+$64M |
-$112M |
-$47.8M |
CDXS, IMMY, AXGN, EPZM, QURE
|
13F-HR |
8/14/2019, 04:30 PM |
Q1 2019 |
53 |
$361M |
+$134M |
-$107M |
+$26.7M |
CDXS, AXGN, EPZM, CERC, AMRN
|
13F-HR |
5/15/2019, 04:30 PM |
Q4 2018 |
47 |
$268M |
+$47.4M |
-$77.6M |
-$30.2M |
CDXS, AXGN, LOXO, AMRN, BPMC
|
13F-HR |
2/14/2019, 05:00 PM |
Q3 2018 |
47 |
$393M |
+$45M |
-$41.1M |
+$3.85M |
AXGN, CDXS, LOXO, AMRN, BPMC
|
13F-HR |
11/14/2018, 04:30 PM |
Q2 2018 |
36 |
$383M |
+$94.3M |
-$90.2M |
+$4.1M |
AXGN, LOXO, CDXS, FGEN, BPMC
|
13F-HR |
8/14/2018, 04:31 PM |
Q1 2018 |
38 |
$350M |
+$70.3M |
-$88.5M |
-$18.2M |
AXGN, BPMC, LOXO, CDXS, FGEN
|
13F-HR |
5/14/2018, 05:00 PM |
Q4 2017 |
35 |
$312M |
+$63.7M |
-$63.9M |
-$234K |
AXGN, BPMC, FGEN, LOXO, IMMU
|
13F-HR |
2/9/2018, 04:30 PM |
Q3 2017 |
34 |
$282M |
+$36.8M |
-$48.1M |
-$11.3M |
BPMC, AXGN, FGEN, IMMU, LOXO
|
13F-HR |
11/14/2017, 04:17 PM |
Q2 2017 |
41 |
$239M |
+$36.2M |
-$30.6M |
+$5.52M |
BPMC, AXGN, FGEN, LOXO, SBBP
|
13F-HR |
8/14/2017, 04:34 PM |
Q1 2017 |
44 |
$201M |
+$40.7M |
-$34.6M |
+$6.15M |
BPMC, AXGN, FGEN, NVLNF, CMRX
|
13F-HR |
5/15/2017, 06:15 AM |
Q4 2016 |
40 |
$168M |
+$44.5M |
-$57.4M |
-$12.9M |
BPMC, AXGN, ARIA, GNMX, FGEN
|
13F-HR |
2/21/2017, 04:27 PM |
Q3 2016 |
44 |
$191M |
+$33.8M |
-$36M |
-$2.19M |
BPMC, AXGN, ARIA, MDGN, AGIO
|
13F-HR |
11/14/2016, 12:30 PM |
Q2 2016 |
49 |
$150M |
+$30.6M |
-$41.1M |
-$10.4M |
AXGN, MDGN, ARIA, FGEN, BPMC
|
Restatement |
8/12/2016, 04:35 PM |
Q1 2016 |
52 |
$147M |
+$32.7M |
-$58.9M |
-$26.2M |
AXGN, ARIA, RARE, FGEN, MDGN
|
Restatement |
5/27/2016, 03:29 PM |
Q4 2015 |
53 |
$239M |
+$50M |
-$42.5M |
+$7.57M |
RARE, AXGN, FGEN, GERN, MDGN
|
13F-HR |
2/12/2016, 12:57 PM |
Q3 2015 |
49 |
$203M |
+$31.5M |
-$49.5M |
-$18.1M |
CMRX, RARE, CEMP, AXGN, MDGN
|
13F-HR |
11/13/2015, 10:44 AM |
Q2 2015 |
46 |
$243M |
+$41.6M |
-$38.2M |
+$3.38M |
CMRX, CEMP, RTRX, AMAG, ARIA
|
13F-HR |
8/14/2015, 10:27 AM |
Q1 2015 |
37 |
$215M |
+$50.1M |
-$67.3M |
-$17.2M |
CMRX, CEMP, ARIA, RTRX, CLVSQ
|
13F-HR |
5/15/2015, 11:41 AM |
Q4 2014 |
36 |
$198M |
+$53.6M |
-$21.3M |
+$32.3M |
CMRX, AGIO, CEMP, RTRX, ARIA
|
13F-HR |
2/13/2015, 07:06 AM |
Q3 2014 |
30 |
$128M |
+$25.7M |
-$14.1M |
+$11.6M |
CMRX, PCYC, RTRX, ARIA, AGIO
|
13F-HR |
11/14/2014, 10:27 AM |
Q2 2014 |
27 |
$116M |
+$30.2M |
-$35M |
-$4.86M |
CMRX, RTRX, ARIA, PCYC, GNMK
|
13F-HR |
8/14/2014, 10:19 AM |
Q1 2014 |
30 |
$135M |
+$63.5M |
-$49.6M |
+$13.8M |
RTRX, ARIA, CMRX, PCYC, NSPR
|
13F-HR |
5/15/2014, 10:48 AM |
Q4 2013 |
23 |
$127M |
$0 |
$0 |
|
GENTY, GERN, PCYC, ARIA, P103PS
|
13F-HR |
2/13/2014, 07:29 PM |